14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

Apricus Biosciences Stock Forecast

NASDAQ:APRI BUY SELL

$1.03 (0%)

Volume: 0

Closed: May 16, 2022

Hollow Logo Score: 0.000

Apricus Biosciences Stock Forecast

BUY SELL NASDAQ:APRI
$1.03 (0%)

Volume: 0

Closed: May 16, 2022

Score Hollow Logo 0.000

APRI Stock Trend

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected.

Given the current horizontal trend, you can expect Apricus Biosciences stock with a 90% probability to be traded between $0.95 and $1.06 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Data

Date Bottom Mid Top
2022-05-18 $0.97 $1.02 $1.08
2022-05-19 $0.97 $1.02 $1.08
2022-05-20 $0.97 $1.02 $1.08
2022-05-23 $0.97 $1.02 $1.08
2022-05-24 $0.97 $1.02 $1.08
2022-05-25 $0.97 $1.02 $1.08
2022-05-26 $0.97 $1.02 $1.08
2022-05-27 $0.97 $1.02 $1.08
2022-05-31 $0.97 $1.02 $1.08
2022-06-01 $0.97 $1.02 $1.08
2022-06-02 $0.97 $1.02 $1.08
2022-06-03 $0.97 $1.02 $1.08
2022-06-06 $0.96 $1.02 $1.07
2022-06-07 $0.96 $1.02 $1.07
2022-06-08 $0.96 $1.02 $1.07
2022-06-09 $0.96 $1.02 $1.07
2022-06-10 $0.96 $1.02 $1.07
2022-06-13 $0.96 $1.02 $1.07
2022-06-14 $0.96 $1.02 $1.07
2022-06-15 $0.96 $1.02 $1.07
2022-06-16 $0.96 $1.02 $1.07
2022-06-17 $0.96 $1.02 $1.07
2022-06-21 $0.96 $1.02 $1.07
2022-06-22 $0.96 $1.02 $1.07
2022-06-23 $0.96 $1.02 $1.07
2022-06-24 $0.96 $1.01 $1.07
2022-06-27 $0.96 $1.01 $1.07
2022-06-28 $0.96 $1.01 $1.07
2022-06-29 $0.96 $1.01 $1.07
2022-06-30 $0.96 $1.01 $1.07

About Apricus Biosciences

Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The company’s marketing partners for Vitaros include Laboratoires Majorelle, Bracco S.p.A., Hexal AG (Sandoz), Takeda Pharmaceuticals Int... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT